Product news from 12/09/05 MM&M News Brief
The FDA has approved Sanofi-Aventis’ Amaryl (glimepiride) Tablets as an adjunct to diet and exercise to lower blood glucose in ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.